Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02767895 · ClinicalTrials.gov registry record · NA
Prehabilitation for PAD Revascularization Patients
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02767895: Clinical Trial NA study, sponsored by University of Michigan.
NCT02767895 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02767895, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Patients undergoing elective revascularization of their peripheral artery disease will be randomized to a prehabilitation program or usual care prior to their scheduled procedure.
Primary Outcome
The feasibility of the study will be assessed by analyzing the recruitment of subjects to the study and the compliance of recruited subjects to the protocol. Feasibility will be defined as able to screening, approaching, and enrolling 25 eligible patients to the pilot study.
Interventions
- BEHAVIORAL Prehabilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2017-11-07 |
| Phase | NA |
Why NCT02767895 stopped before completion
NCT02767895 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Prehabilitation is the first listed.
NCT02767895 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02767895 about?
NCT02767895 is a clinical study titled "Prehabilitation for PAD Revascularization Patients". Patients undergoing elective revascularization of their peripheral artery disease will be randomized to a prehabilitation program or usual care prior to their scheduled procedure.
What is the current status of trial NCT02767895?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2016-07-01. Estimated completion is 2017-11-07.
What interventions are being tested in trial NCT02767895?
The interventions under investigation include: Prehabilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT02767895?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02767895's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI